Trump Responds to ‘Dilbert’ Creator Scott Adams’s Plea to ‘Help Save My Life’ as He Fights Prostate Cancer

By Jack Phillips
Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
November 2, 2025Updated: November 2, 2025

President Donald Trump on Sunday responded to “Dilbert” comic strip creator and political commentator Scott Adams’s request to help expedite the scheduling of a drug to help treat an aggressive form of prostate cancer afflicting him that he disclosed earlier this year.

Adams, a prominent early Trump supporter who announced in May that he has late-stage prostate cancer, wrote in a post on X on Saturday that his health care provider, Kaiser Permanente, approved his application to receive a new FDA-approved drug called Pluvicto.

“But they have dropped the ball in scheduling the brief IV to administer it and I can’t seem to fix that. I am declining fast,” Adams wrote in the post, referring to the health care provider. “I will ask President Trump if he can get Kaiser of Northern California to respond and schedule it for Monday. That will give me a fighting chance to stick around on this planet a little bit longer. It is not a cure, but it does give good results to many people.”

Responding to Adams’s request, the president wrote on Truth Social: “On it.” Meanwhile, Health and Human Services Secretary Robert F. Kennedy Jr. wrote in a Sunday post on X: “Scott. How do I reach you? The President wants to help.”

The FDA in 2022 approved the Novartis-made drug for treatment of “metastatic castration-resistant prostate cancer,” while the agency in March 2025 expanded its usage.

Pluvicto is described as a radioactive drug used to treat a type of prostate cancer that has metastasized to other areas in the body. It can be administered to cancer that isn’t responding to other standard treatments.

“This radioactive medicine is a new option for someone with prostate cancer that has spread to other areas of the body,” says the University of Virginia Health System website. “Pluvicto isn’t a cure for cancer. But it can help some men live longer and slow the growth of their tumors.”

Adams, known for creating “Dilbert,” pivoted to becoming a political commentator around the time Trump ran for president during the 2016 election. In May of this year, Adams said during his podcast that he has the same type of prostate cancer as former President Joe Biden and that he only has months to live.

“I have the same cancer that Joe Biden has. I also have prostate cancer that has also spread to my bones,” he said during his “Coffee with Scott Adams” podcast. “My life expectancy is maybe this summer. I expect to be checking out from this domain sometime this summer.”

Adams, 68, said at the time that his disease “is already intolerable.”

“I can tell you that I don’t have good days. So if you are wondering, ‘Hey Scott, do you have any good days’? Nope. Nope. Every day is a nightmare and evening is even worse,” he continued.

Before Adams’s announcement, a spokesperson for Biden said that he was dealing with an aggressive form of prostate cancer with a Gleason score of 9, and it had spread to the bone. In mid-October, Biden’s spokesperson confirmed that the former president and vice president was receiving hormone and radiation treatments.

Roughly one in eight men will be diagnosed with prostate cancer in their lifetime, according to the American Cancer Society. It’s the second-most common cause of cancer-related deaths among men in the United States behind lung cancer.